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Abstract
Echocardiography is fundamental for the management of infective endocarditis (IE)
across all stages of the illness including diagnosis, surveillance during medical therapy,
identification of prognostic markers, planning perioperative intervention, postoperative
assessment, and follow-up after completion of definitive therapy. Modern era echocar-
diography (echo) offers outstanding temporal and spatial image resolution, providing
the opportunity for early diagnosis of this life-threatening infection. Emerging imaging
modalities, such as real-time three-dimensional (3D) echocardiography, offer a novel
way of readily visualizing the extent of intracardiac infection and the relationship of
pathology to adjacent cardiac structures,  well  before surgical intervention, without
radiation exposure or significant  risk to the patient.  Echocardiography can have a
positive impact on the management of every stage of this disease, with the opportunity
to improve outcomes.
Keywords: transthoracic echocardiography, transesophageal echocardiography, 3D
echocardiography, infective endocarditis, cardiac device-related endocarditis, left-sid-
ed endocarditis, right-sided endocarditis, native valve infection, prosthetic valve in-
fection, vegetation, abscess, diagnosis, congenital heart disease, diagnostic accuracy,
sensitivity, specificity, management, surgery, cardiac imaging, intracardiac ultrasound
1. Introduction
Echocardiography  is  fundamental  to  the  diagnosis,  risk  stratification,  management,  and
follow-up of patients with IE [1].  Modern era transthoracic echocardiography (TTE) and
transesophageal echocardiography (TEE) enable cardiac anatomy, pathology, and physiology
to be assessed in real time. Echocardiography is a readily available, portable imaging modality
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that uses the properties of reflected ultrasound waves to construct high-quality two-dimen-
sional  (2D)  and three-dimensional  (3D)  images of  the  heart  without  radiation exposure.
Echocardiography should be utilized at the first opportunity when IE is suspected, to provide
an early diagnosis and facilitate important management decisions. However,  echocardio-
graphic findings should always be interpreted in their clinical context to maximize diagnostic
utility.
This chapter will outline the role echocardiography in the management of IE. In addition, the
history of cardiac ultrasound, its diagnostic accuracy, limitations, and emerging technologies
such as 3D imaging will be reviewed. Finally, there is a section on imaging protocols and quality
control to provide guidance to echocardiography laboratories wishing to pursue excellence in
the field.
2. Diagnosis
The modified Duke criteria [2] is used to categorize endocarditis as definite, possible or rejected
based on clinical, microbiological, echocardiographic, and pathological findings. Blood
cultures and echocardiography are the two key criteria for IE. The modified Duke criteria [2]
has an overall sensitivity of ∼80–90%, and specificity >90% for diagnosis of IE when compared
to pathological diagnosis; however, it is less reliable for identification of prosthetic valve
endocarditis (PVE) with sensitivity ∼70–80% [3–7]. Transesophageal echocardiography has
been shown to improve the diagnostic accuracy of the Duke criteria for definite IE when
compared with TTE imaging [8].
A high-clinical suspicion for IE should be adopted especially when fever is present in patients
with a prosthetic valve or device, new murmur or heart block, underlying valvular disease or
congenital heart disease (CHD), embolism, immunosuppression, previous IE, or intravenous
drug abuse (IVDA). It is imperative for early blood cultures be collected prior to antibiotic
therapy and urgent echocardiography performed.
2.1. Major Duke echocardiographic findings
The three major echocardiographic findings as defined by the modified Duke criteria [2]
suggesting direct evidence of endocardial involvement are vegetation, abscess, and new partial
dehiscence of a prosthetic valve.
Vegetation is seen as a high frequency independently oscillating mass typically located on the
low-pressure side of cardiac valves, in particular the atrial aspect of the atrioventricular (mitral
and tricuspid) valves and the outflow tract side of the semilunar (aortic and pulmonary)
valves (Figure 1). Less often, vegetations can be sessile with little or no mobility or have mixed
sessile and mobile components.
Vegetations are commonly attached along the leaflet coaptation zone, although it can be lo-
cated anywhere on the valve leaflet, annulus, and subvalvular apparatus. They are also fre-
quently found in the path of abnormal turbulent blood flow (‘jet lesion’) arising from
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valvular regurgitation, a shunt or may spread to adjacent structures by direct contact (‘kiss-
ing lesion’). Vegetations may also be attached to the endocardial surface lining the heart
chambers (mural) or blood vessels (intraluminal). With an aging population and increased
cardiac interventions, vegetations involving prosthetic valves, pacing leads, and other non-
biological intracardiac materials are becoming more prevalent (Figure 2).
Figure 1. 3D TEE en-face view of mitral valve demonstrating multiple vegetations (arrows).
Figure 2. TEE mitral valve with large vegetation causing a ‘stuck’ anterior mechanical occluder (arrow).
A vegetation has a similar ‘gray scale’ ultrasound reflectance (echogenicity) to normal
myocardium. Chronic ‘healed’ vegetations, however, often become partly calcified and
therefore appear more echogenic when compared to surrounding structures. Vegetations
usually have a soft ‘shaggy’ irregular inhomogeneous appearance on echocardiography
helping to differentiate them from simple degenerative valvular tissue strands such as Lambl’s
excrescences, which tend to be very thin linear structures (Figure 3). Vegetations may reduce
in size with treatment, embolize, or remain unchanged.
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Figure 3. TEE demonstrating the common finding of a degenerative ‘Lambl’s excrescence’ attached to the LVOT aspect
(arrow) of the aortic valve.
Differential diagnoses for such masses include fibrin and thrombus, which are frequently
extremely difficult, if not impossible to distinguish from vegetations on ultrasound imaging.
Other findings, such as pannus and tumors, often have a characteristically distinct appearance
from vegetations, albeit subtle, and therefore, it is not always possible to differentiate from one
another. While imaging cannot specifically identify the type of microorganism, the appearance/
complications of a vegetation may suggest infective agents, for example, fungal vegetations
tend to grow to a very large size, and staphylococcus is associated with abscess.
A minority of vegetations are noninfective in origin and referred to as nonbacterial thrombotic
endocarditis (NBTE). According to one study [9], lesions resembling NBTE vegetations were
identified by echocardiography frequently in patients with antiphospholipid syndrome/
Libman–Sacks (63%), myeloproliferative disorders (63%), and solid-organ malignancies (19%).
The lesions most often resembled typical vegetations, but also diffuse valve involvement (e.g.,
Figure 4), with a verrucous appearance can occur [9–11].
Figure 4. Diffuse, ‘verrucous’ (arrows) thickening of mitral leaflets in Libman–Sacks endocarditis. Three-dimensional
TEE mitral valve (LVOT aspect) and 2D TEE mid esophageal view, mitral valve.
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Intracardiac abscesses appear as inhomogeneous echolucent or occasionally echodense
regions, involving the periannular tissue or myocardium, comprised of necrotic and purulent
material. A developing abscess may present as a region of periannular thickening (≥10 mm)
and is referred to as a phlegmon. Importantly, there is no color flow on Doppler imaging into
an abscess from the vessel lumen or cardiac chamber.
Abscesses are detected in patients undergoing surgery for endocarditis at the aortic annulus
in 33–50% of cases, but only 10–20% are located at the mitral annulus [12–14]. Abscesses
account for a higher proportion of complications in PVE (Figure 5) and often require surgical
intervention [12, 15]. Intervalvular extension of the abscess posteriorly to involve the mitral–
aortic intervalvular fibrosa (MAIVF) occurs in approximately two-thirds of aortic periannular
infections [16]. In the early stages following aortic valve or root surgery, it may be difficult to
distinguish normal postoperative periaortic edema and hematoma from an abscess.
Figure 5. TEE demonstrating posterior periprosthetic aortic abscess (arrow).
Figure 6. 3D TEE en face of a prosthetic mitral valve with dehiscence at the lateral annulus (arrow).
Mitral annular abscess is often located at the mural annulus, particularly the posterior or lateral
annular margin [17], rather than the septal annulus [14]. Mitral annular abscess is more
frequently associated with pseudoaneurysm formation and/or fistula than aortic abscess.
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Complications include rupture into the coronary sinus, left circumflex artery, or the pericar-
dial space [14]. The presence of mitral annular calcification (MAC), especially caseous
calcification, can make diagnosis of annular abscess more challenging due to acoustic shad-
owing artifact.
New dehiscence of a prosthetic valve occurs when there is disruption of the annular sewing
ring due to a breakdown of supporting tissue adjacent to the prosthesis (Figure 6). This results
in perivalvular regurgitation and may be associated with an abnormal rocking motion. If the
area of dehiscence around a bioprosthetic aortic valve is <30%, concordant motion of the valve
with the aortic root will occur; however, if >40% of annular area is dehisced, discordant or
rocking valvular motion will be present (Figure 7) [18].
Figure 7. TEE color flow imaging from the ‘long-axis’ window demonstrating severe periprosthetic aortic valve regur-
gitation complicating annular dehiscence (arrow). A large region of dehiscence results in a ‘rocking’ motion of the
prosthetic valve.
2.2. Minor Duke echocardiographic findings
Minor echocardiographic findings include but are not limited to perforation, valve aneurysm,
fistula, pseudoaneurysm, valve leaflet destruction, and flail leaflet [2].
Figure 8. TEE color compare imaging of mitral valve vegetation with perforation (arrow) and severe regurgitation.
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The first case report of TEE used to diagnose a perforation was published in 1991 [19]. A
perforation is typically a defect through the valvular tissue, separate from the commissures
and leaflet margins, well circumscribed and with a ‘punched out’ appearance on 3D imaging.
The finding of a suspected perforation on 2D or 3D echo must be confirmed by demonstrating
Doppler color flow traversing the body of the leaflet, typically characterized by flow conver-
gence with a proximal isovelocity surface area (PISA) dome (Figure 8).
A valvular aneurysm occurs as a localized bulging sac of the valve leaflet tissue with pulsatile
flow seen into the region during systole. The lesion most commonly involves the anterior mitral
valve leaflet (AMVL) and usually arises secondary to aortic valve endocarditis [20, 21]. This
occurs by either an infected aortic valve regurgitant jet ‘seeding’ the AMVL or alternatively,
from contiguous spread along MAIVF. Localized infection of the mitral leaflet may be followed
by valve aneurysm, perforation, and/or leaflet destruction [21].
Cardiac fistula is an uncommon, serious complication, occurring in <1–2.2% [22, 23] of patients
with endocarditis and 6–9% of cases when abscess is present [22]. Fistulae often arise from the
aortic root or the left ventricular outflow tract [24]. Aortic root fistulas form communications
between the aorta and cardiac chambers (aortocavitary) and/or pericardial space (aortoperi-
cardial) and often result in hemodynamic compromise. Fistulas can also arise between cardiac
chambers [25].
A pseudoaneurysm is defined on echocardiography as an echolucent space communicating
with an adjacent cardiac chamber or with the aortic lumen. Blood enters into the cavity under
pressure during systole and is seen as pulsatile flow on color Doppler imaging. Pseudoaneur-
ysms frequently arise from the MAIVF with a communication to the left ventricular outflow
tract through the narrow ‘neck’ of the aneurysmal sac [16]. Rupture of a pseudoaneurysm can
result in a fistulous connection with the pericardial space, left atrium, or aortic lumen [16, 26].
3. Indications and appropriateness criteria for echocardiography
3.1. American-based guidelines
According to the 2014 ACC/AHA guidelines [27], TTE is indicated in patients with suspected
IE to identify vegetations and assess valve hemodynamics, ventricular function, pulmonary
pressures, and cardiac complications (class I recommendations). Transesophageal echo is
indicated when TTE is nondiagnostic in suspected or known IE, including when intracardiac
devices are present and to assess intracardiac complications of IE (class I recommendations).
Up to 30% of Staphylococcus aureus bacteremia are associated with IE, and therefore, TEE should
be strongly considered. In cases where fever defervesced within 72 h and there is a clear
extracardiac source (excluding osteomyelitis, spinal involvement, intracardiac device, hemo-
dialysis, structural cardiac disease, prolonged bacteremia, or risk factors), TEE may not be
necessary [27].
Another set of independent Guidelines that were published in 2011 by the American College
of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria
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Working Groups in consultation with other key organizations, developed a scoring system
graded from 1 to 9, with 7–9 being an appropriate echo referral, 4–6 uncertain, and 1–3
inappropriate [28]. A summary of the guideline is provided as follows:
3.1.1. Transthoracic imaging
Imaging of native or prosthetic valves is considered most appropriate (grade 9) where
endocarditis is clinically suspected and associated with positive blood cultures or a new
murmur. In addition, TTE is indicated for reevaluation of IE if any of the following are present
as follows: (a) high risk of progressive disease, (b) change in clinical status of the patient, and/
or (c) new clinical findings on cardiac examination [28].
Inappropriate reasons for performing TTE include transient fever (without bacteremia or new
murmur) and cases of transient bacteremia with a non-IE pathogen and/or documentation of
noncardiovascular infection. Also, performing echocardiography for routine surveillance
without complications or when findings would not change management, is considered
inappropriate and should be avoided [28].
3.1.2. Transesophageal imaging
Appropriateness guidelines for the use of TEE are more generic and are not necessarily specific
for endocarditis. The use of TEE is considered reasonable in the following situations: (a) it is
anticipated TTE imaging would be suboptimal, (b) to assess for interval change, if it is likely
to guide a change in therapy, (c) assess valvular structure for planned interventions, and (d)
to diagnose endocarditis if moderate pretest probability in certain subgroups, such as staph-
ylococcal bacteremia or fungemia, prosthetic valves or intracardiac devices [28].
Inappropriate indications include the following: (a) if TTE is likely to be diagnostic, (b) follow-
up TEE, when anticipated it would not change therapy, and (c) to diagnose IE with a low pretest
probability [28].
3.2. European-based guidelines
The 2015 European Society of Cardiology (ESC) Guidelines on the management of IE provide
an alternative set of guidelines on the appropriate use of echocardiography, grouped according
to management stage of the illness [17]. A summary of the guideline is provided as follows:
3.2.1. Diagnosis
Class I indications include the following: (a) TTE first line in suspected IE, (b) TEE if negative
TTE or nondiagnostic but clinical suspicion of IE, (c) TEE if clinical suspicion of IE if prosthetic
valve or cardiac device is present, (d) repeat TTE and/or TEE if initial examination negative
but high-clinical suspicion.
Class IIa indications include the following: (a) consider echo for Staphylococcus aureus bacter-
emia and (b) consider TEE in all suspected cases of IE regardless of TTE findings, unless high-
quality study of native right-sided uncomplicated infection.
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3.2.2. Follow-up during medical therapy
A class I indication to repeat either TTE and/or TEE is recommended if a new complication is
clinically suspected. Consideration to repeat the TTE and/or TEE without complication is given
a class IIa indication. The reasoning relates to the possibility of detecting a clinically silent
complication and the ability to monitor vegetation size. This class IIa recommendation
suggests the frequency of serial imaging should be based on factors such as the initial pathol-
ogy, type of organism, and the response to treatment.
3.2.3. Intraoperative echocardiography and follow-up after completion of therapy
Class I indications include the following: (a) Each patient should undergo intraoperative
echocardiography and (b) follow-up TTE should be performed at the completion of antibiotic
therapy.
It is also recommended TTE be performed on a periodic basis along with clinical assessment
during the first 12 months following discharge to monitor for the development of heart failure
[17]. Consideration should be given to repeat TTE at 1, 3, 6, and 12 months [1].
3.3. Summary of guidelines
The American and European guidelines are similar in most regards; however, the ESC
recommendations place emphasis on performing TTE on all patients with suspected IE and
suggest consideration be given to progress imaging during the course of treatment, even when
there is no change in clinical status. These guidelines are important to provide physicians with
direction on the appropriateness of imaging referrals.
4. Important subgroups of endocarditis
4.1. Prosthetic valve endocarditis
Prosthetic valve endocarditis incidence is estimated at 0.3–1.2% per patient-year and accounts
for approximately 10–30% of all cases of IE [6, 29]. Infection is classified as early or late PVE
(>12 months postsurgery) and is associated with a different microbiological profile [30]. The
infection rates are similar for mechanical and bioprosthetic valves, although lower for mitral
valve repair [6, 31, 32]. A large multicenter registry study found that the incidence of endo-
carditis in transcatheter aortic valve implantation (TAVI) was 0.5% by 12 months, with almost
half of the patients not surviving to discharge [33].
Mechanical prostheses are prone to periannular complications due to infection of the sewing
ring predisposing to abscess, fistula, and/or dehiscence and are more likely to occur within the
first few months postsurgery. Bioprosthetic valves primarily seed vegetations on the leaflets
which may progress to ulceration, perforation, and/or leaflet destruction [34].
Echocardiographic imaging is more challenging in PVE, particularly with mechanical valves,
due to reverberation and acoustic shadowing. Periannular involvement is common and may
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be obscured by artifact from the valve prosthesis [34]. Mechanical prosthetic valves are
susceptible to formation of adherent thrombus and pannus, while bioprosthetic valves
degenerate over time and can develop tissue strands or leaflet tears which can mimic vegeta-
tions [35].
Transesophageal echo is superior for assessment and detection of mitral and aortic prosthetic
valve abnormalities, including endocarditis, thrombus, and degenerative changes, particularly
for mechanical prosthetic valves [36]. Imaging with TTE is limited by the availability of an
acoustic window, intervening anatomical structures between the probe and the heart, lower
transducer frequency, and acoustic shadowing [36]. Multiplane TEE is highly effective for
detecting mechanical valve periprosthetic mitral regurgitation (Figure 9), unlike TTE in which
acoustic artifact obscures the left atrial aspect of the image [37].
Figure 9. TEE color compare showing prosthetic annular dehiscence (arrow) associated with significant mitral regurgi-
tation.
Although color and spectral Doppler assessment of prosthetic valves should be performed
during TTE and TEE examinations, transthoracic echo is preferred for assessment of hemo-
dynamics. In the case of a mechanical prosthetic aortic valve, TTE is also superior when
assessing the anterior aortic root for abscess as acoustic shadowing is posteriorly directed
obscuring the TEE image.
Aortic and mitral mechanical valve occluder motion is difficult to assess with TTE. The use of
2D and 3D TEE offers excellent assessment of mitral occluder motion; however, it is often
suboptimal at visualizing the aortic occluders. The addition of cine fluoroscopy can definitively
assess occluder-opening angles, while multidetector-row computed tomography (MDCT) is
useful for evaluating occluder motion and identifying any mass lesions [38].
4.2. Right-sided endocarditis
Right-sided endocarditis (RSE) is epidemiologically distinct from left-sided cardiac infection
and is associated with a lower mortality, except when vegetations are ≥20 mm [39]. Often
vegetations are larger in size nevertheless infrequently associated with periannular extension
[40].
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The three major subgroups of RSE include IVDAs, cardiac device-related IE (CDRIE), and
CHD. A minority of cases do not fit into any category, usually occurring in patients with
structurally normal valves and a history of an indwelling venous catheter for treatment of an
unrelated medical condition. This group may have a higher risk of periannular complications.
In addition, left-sided IE, such as periannular aortic infection, can extend to involve the right-
sided cardiac valves [40].
Endocarditis in IVDAs is more frequently associated with fungal and polymicrobial infections,
both of which carry a much higher mortality than the expected 5–10% in RSE [39]. Endocarditis
in the IVDA group most commonly involves the tricuspid valve with S. aureus the usual culprit.
Infection rates are higher in HIV-seropositive and HIV-immunosuppressed individuals [40].
4.3. Cardiac device-related infections
Cardiac device-related endocarditis occurs in patients with pacemakers or implantable cardiac
defibrillators, which are more prevalent in the older patient cohort. Endocarditis usually
involves the presence of vegetations on the device lead, valves, or mural endocardium.
Infective endocarditis must be distinguished from localized pocket site infection.
Echocardiography is fundamental for early diagnosis of CDRIE; nonetheless, it can be
technically challenging due to artifact shadowing from the pacing leads. Transesophageal
imaging is usually required and permits visualization of the leads, venae cavae, and high right
atrial wall, which are often difficult to comprehensively investigate with TTE.
Small strands known as accretions are noted incidentally on device leads in approximately
30% of patients without clinical evidence of IE [41, 42]. The lesions appear as thin (1–2 mm)
strands or occasionally as fixed small nodular echogenic structures on the leads and are not
associated with a poorer prognosis [41].
4.4. Congenital heart disease
The incidence of IE in children is estimated at 0.34–0.64 per 100,000 person years, respectively,
approximately ten times less common than in adults. Underlying CHD is found in 11–13% of
adults with IE [43]. The most common underlying risk factor in children for endocarditis is
CHD, followed by indwelling catheters. Rheumatic heart disease is now rare in developed
countries. Only 2–5% of cases of IE occur in children with structurally normal valves compared
to 25–45% of adults [44].
The main advantage of TTE over TEE is the need for anesthesia and intubation is avoided [44].
Transesophageal echocardiography should be utilized when TTE is negative but a high-clinical
suspicion of IE remains, especially for periannular complications [45]. There are limited data
comparing TEE with TTE in adult CHD. Both TTE and TEE may not adequately visualize
vegetations or periannular complications associated with prosthetic shunts and conduits.
Cardiac CT or MRI could be helpful in this setting [46].
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5. Diagnostic accuracy
5.1. M-mode echocardiography
The first moving pictures of the heart using an ultrasound reflectoscope were recorded and
published in 1953, by the ‘father of echocardiography’ Inge Edler, along with physicist
Hellmuth Hertz. This led to the development of the standard time–motion (M-mode) ultraso-
noscope, which later became known as an echocardiogram and depicted a single-imaging
dimension displayed along a time axis [47].
Reference  No. of
patients 
No. of Vg or valves 
involved by
gold standard* 
Sensitivity
and
specificity for
Vg 
TTE  TEE 
NV
(%) 
PV
(%) 
PV
(%)
NV
+ 
NV
(%) 
PV
(%) 
NV +
PV
(%) 
Stafford et al. [53] n = 62 n = 29
Sx/path
sens – – 93 – – –
spec – – 89 – – –
Erbel et al. [54] n = 96 AV = 15
MV = 3
PPM = 1
Sx/path
sens 63 – – 100 – –
spec 98 – – 98 – –
Mügge et al. [55] n = 105 NV = 69
PV = 22
Sx/path
sens D 68 27 58 94 77 90
P 90 36 77 100 86 97
spec – – – – – –
Daniel et al. [36] n = 126 PV = 33
Sx/path
sens – 36 – – 82 –
spec – – – – – –
Shapiro et al. [56] n = 64 NV+
PV = 30
TTE + TEE
sens – – 60 – – 87
spec – – – – – –
Lowry et al. [57] n = 93 Clinical ±
path (n = 29)
sens 50 17 36 100* 83* 93*
spec 78 94 83 89* 95* 91*
Irani et al. [58] n = 134 n = 60#
TEE*
sens 68 – – – – –
spec 100 – – – – –
Vg’s = vegetations; TTE = transthoracic echocardiography; TEE = transesophageal echocardiography; NV = native
valve; PV = prosthetic valve; n = number; Sx = surgery; path = pathological diagnosis, either surgical tissue or at
autopsy; AV = aortic valve; MV= mitral valve; PPM = pacemaker lead; sens = sensitivity; spec = specificity; D = definite
vegetations seen on echocardiography; P = possible vegetations in addition to definite vegetations seen on
echocardiography. *Includes studies using biplane and/or multiplane TEE; # total number included vegetations and/or
abscesses detected by TEE
Table 1. Diagnostic accuracy of TTE and TEE for detection of predominantly left-sided cardiac vegetations, pre
harmonic era TTE imaging.
The first study to demonstrate vegetations using M-mode echocardiography was published in
1973 [48], followed by a case report of a tricuspid valve vegetation detected in 1974 [49]. Early
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work demonstrated M-mode was able to detect approximately one-third of native valve
vegetations in patients with a clinical and/or pathological diagnosis of IE [50, 51].
Real-time 2D and 3D echocardiographic imaging, along with color and spectral Doppler
capabilities, has superseded M-mode. The culmination of these advancements has enabled
echocardiography to emerge as the imaging gold standard for IE and as such, be incorporated
into the modified Duke [2] as a major diagnostic criterion. M-mode now contributes little to
imaging in IE, except to demonstrate the typical vibrations of vegetations and/or prolapse of
valvular tissue with high-temporal resolution (>1000 Hz cf. 30–60 Hz with 2D).
Reference  Gold
standard* 
Valve
type 
TEE—number of involved valves or vegetations by
location
Sens
TTE %
Spec
TTE %
NV PV PPM
lead 
Other
site 
Total 
Barton et al. [61] TEE NV + PV MV = 50
AV = 34
TV = 19
MV = 16
AV = 25
n = 11 n = 1 n = 156 58
68#
–
Kini et al. [62] TEE NV + PV n/a n = 51 n/a n/a n = 179 45 79
Casella et al. [63] TEE NV AV = 21
MV = 15
TV = 2
87
82^
86
62^
Jassal et al. [64] TEE NV AV = 13
MV = 6
– – – n = 19 84 88
Chirillo et al.
[65]
TEE NV + PV AV = 11
MV = 10
TV = 3
AV = 3
MV = 6
– – n = 33 82 (HI)
36 (FI)
98 (HI)
80 (FI)
Reynolds et al,
[66]
TEE NV AV=24 MV=26
TV=1
– n = 2 n = 2 n=55 (valves,
n= 51)
55 –
Vg’s = vegetations; TTE = transthoracic echocardiography; TEE = transesophageal echocardiography; NV = native
valve; PV = prosthetic valve; n = number; AV = aortic valve; MV= mitral valve; TV = tricuspid valve; n/a = not available;
sens = sensitivity; spec = specificity; HI = harmonic imaging; FI = fundamental imaging. *modality against which
sensitivity of TTE was compared; ^Included both definite and intermediate likelihood of IE on echocardiography; #
sensitivity of TTE for detection of native valve vegetations, excluding prosthetic intracardiac material.
Table 2. Diagnostic accuracy of TTE compared to TEE for detection of predominantly left-sided cardiac vegetations
utilizing modern era tissue harmonic imaging.
5.2. Transthoracic echocardiography
In the early 1970s real-time, phased array 2D TTE transducer technology was introduced,
providing spatial resolution and anatomical detail not previously seen. This provided not only
the ability to identify vegetations like its predecessor M-mode, but to accurately describe the
size, point of attachment and morphology of intracardiac masses [52].
5.2.1. Vegetations
During the 1980s and 1990s, numerous landmark studies were published comparing the
diagnostic accuracy of TTE for identification of predominantly left-sided cardiac vegetations.
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Transthoracic echo was shown to have a combined sensitivity of 36–93% for native and
prosthetic valve vegetations and a specificity of 78–100% (Table 1).
5.2.1.1. Harmonic tissue imaging
Harmonic sound waves are reflected back to the transducer at twice the frequency of the
transmitted wave (fundamental frequency) and are subject to less near-field distortion and side
lobe artifact. This results in a better signal-to-noise ratio with superior image resolution [47].
Specifically, there is an improvement in endocardial definition and visualization of the cardiac
valves. However, the valve leaflet tissue itself may appear abnormally thickened when viewed
using harmonic imaging [59, 60].
A number of studies have revisited the question of diagnostic accuracy of TTE for identification
of mostly left-sided native valvular vegetations by comparing findings directly with TEE using
modern era tissue harmonic imaging (hTTE). It remains unclear if modern era TTE imaging
has resulted in improved detection of vegetations for left-sided vegetations, due to the wide
variation in results reported (Table 2).
Reference Gold
standard*
No. abscesses
confirmed by gold
standard*
TEE multi-
plane# 
Sensitivity &
Specificity 
TTE TEE
NV PV NV
+PV 
NV PV NV +
PV 
Daniel et al. [67] Sx 46 (NV + PV) No sens – – 28 – – 87
spec – – 99 – – 95
Aguado et al.
[15] 
Sx/path 25 (NV)
11 (PV)
No sens – 64 81 – – –
spec – – 85 – – –
Choussat et al.
[12]
Sx 64 (NV)
43 (PV)
Yes sens 33 40 36 75 88 80
spec – – – – – –
San Román et al.
[24] 
Sx/path 30 (PV) Yes sens – – – – 90 –
spec – – – – 100 –
Cicioni et al. [68] Sx 29 (NV + PV) Yes sens – – 38 – – 93
spec – – – – – –
TTE = transthoracic echocardiography; TEE = transesophageal echocardiography; NV = native valve; PV = prosthetic
valve; sens = sensitivity; spec = specificity; Sx = surgery; path = pathology, either confirmed with surgery or at autopsy.
*modality against which sensitivity and specificity of TTE and/or TEE was compared against. #Multiplane TEE probe
transducer utilised for imaging in some or all patients in a study.
Table 3. Diagnostic accuracy of TTE and TEE for detection of abscess.
5.2.2. Abscess
Published data on diagnostic accuracy vary widely for abscess detection by TTE. Sensitivity
has been reported at 28–81% with specificity 85–100% (Table 3). It is uncertain if harmonic
imaging has positively impacted on the diagnostic accuracy, with some studies reporting no
improvement [65, 68].
Contemporary Challenges in Endocarditis72
5.2.3. Other complications
There are limited studies, generally with small patient cohorts, assessing the diagnostic
accuracy of echocardiography for identifying complications other than vegetation and abscess.
Information regarding accuracy of TTE for identifying pseudoaneurysms is sparse, mostly
because this pathological finding is often included in with the abscess group. According to one
publication, only about one-half of intervalvular pseudoaneurysms were correctly diagnosed
by TTE [21].
The sensitivity of TTE is approximately 50% [23] for detection of aorto-cavitary fistulas, but as
high as 93% for detecting periannular dehiscence [68]. Detection rates for perforations with
TTE range from 45 to 75% [68, 70, 71] and similar for valve aneurysms (38–75%) when
compared with TEE as the gold standard [20, 72]. Not surprisingly valve aneurysms are most
likely to be missed on TTE when small in size [21, 73].
Reference Cohort  Number
 of patients
Gold standard * Diagnostic sensitivity of imaging modality
M-Mode %  2D TTE %  2D TEE %  ICE % 
Berger et al. [75] IVDA 12 Clinical 60 83 – –
Ginzton et al. [76] IVDA# 16 Clinical 63 100 –
Klug et al. [77] CDRIE 52 Clinical ± Sx – 23 94 –
Cacoub et al. [78] CDRIE 33 Clinical ± Sx – 22 96 –
Victor et al. [42] CDRIE 23 Clinical ± micro – 30 91 –
Narducci et al. [79] CDRIE 44 Clinical
(‘definite’IE group)
– – 73 100
IVDA = intravenous drug abuse; CDRIE = cardiac device-related infective endocarditis; TTE = transthoracic
echocardiography; TEE = transesophageal echocardiography; ICE = intracardiac echocardiography; sens = sensitivity;
spec = specificity; Sx = surgery; micro = microbiological diagnosis. *modality against which sensitivity and specificity
of echocardiography was compared against; #majority of patient cohort were IVDA
Table 4. Diagnostic accuracy of TTE and TEE for right-sided valvular and cardiac device-related vegetations.
5.2.4. Subgroups of endocarditis
Limited data have been published addressing the sensitivity of TTE in RSE [74]. For tricuspid
valve IE, mostly in the IVDA cohort, sensitivity is high at 83–100% [75, 76], while detection
rates in CDRIE are poor at 22–30% (Table 4). Transthoracic echo may be adequate for isolated
native tricuspid valve IE, especially in IVDAs, unless image quality is suboptimal or if clinical
suspicion remains despite negative TTE. Transesophageal echo should be utilized if there may
be periannular infection, pulmonary, or left-sided valvular involvement or in the presence of
an indwelling intravenous catheter [40].
The sensitivity of echocardiography for diagnosis of IE in CHD overall is estimated at 60–80%,
but less sensitive if complex pathology is present [46]. In one study, approximately one-third
of adult patients with CHD and a clinical diagnosis of IE had negative findings on TTE
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and/or TEE and up to 70% of echocardiograms were negative in palliated complex conditions
[80].
In young children, TTE is often sufficient to diagnose IE due to superior acoustic windows
compared to adults. Transthoracic echo in children with IE has a high rate of detection of
vegetations (>90%) when compared with TEE as the gold standard [81].
5.3. Transesophageal echocardiography
Transesophageal echo using monoplane imaging transducers was introduced into clinical
practice in the early 1980s. The spatial resolution and utility of 2D TEE has continued to
improve with the introduction of biplane and subsequent multiplane TEE transducers along
with other advances in probe technology, digital processing, and image display.
5.3.1. Vegetations
During the 1980s and 1990s, with the introduction of monoplane TEE, a number of landmark
studies were published comparing the diagnostic accuracy of TEE for identification of
vegetations against the gold standard of surgery or pathological findings. Reported sensitiv-
ities and specificities of TEE for detection of left-sided vegetations ranged from 94 to 100% and
77 to 95% for native and prosthetic valves, respectively. Specificity was consistently high at
>90% (Table 1).
A few studies compared monoplane, biplane, and multiplane TEE. Earlier work found
marginally higher detection rates of vegetations and/or abscesses, but differences were
minimal [82, 83]. Monoplane TEE not only underestimated vegetation size and extent but also
was found to be less accurate at detecting small vegetations [83]. Contemporary studies using
multiplane imaging report sensitivities >90% [68, 84]. Considering TEE imaging has always
demonstrated high sensitivity and specificity for detection of vegetations, it is unclear if
multiplane imaging has improved the diagnostic accuracy.
The reported sensitivity of 2D TEE for detection of vegetations in CDRIE ranges from 73 to
96% (Table 4) and is also superior over TTE for distinguishing site of attachment, whether
valvular or on a lead.
5.3.2. Abscess
Three landmark studies from the 1990s investigated diagnosis of abscess by echocardiography
comparing findings with surgery or autopsy. Daniel et al. [67], Choussat et al. [12], and San
Román et al. [24] found that the sensitivity of TEE for abscess was 87, 80, and 90%, respectively.
However, other studies have reported greater variability, with sensitivities ranging from 48 to
93%. Specificity has consistently remained high at >90% (Table 3).
It is unclear whether detection rates for abscesses have improved since the introduction of
multiplane TEE. Although more recent studies in Table 3 utilized biplane and multiplane
imaging, the results did not demonstrate a significant improvement in diagnostic accuracy.
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5.3.3. Other complications
Similar to TTE, there are limited studies with small patient cohorts assessing the diagnostic
accuracy of TEE for identifying the complications of IE, other than vegetation and abscess.
Accurate detection of perforations is relatively high, ranging from 75 to 100% [68, 70, 71].
Transesophageal echo is the imaging modality of choice for identifying valve aneurysms,
although sensitivity is unknown [73, 85], while aorto-cavitary fistulas are almost always
identified correctly, with a sensitivity of 97–100% [23, 24]. Perivalvular dehiscence can be
accurately diagnosed in the majority of cases with a sensitivity of 71–100% [68, 69, 86, 87] and
specificity of >90% [69].
5.4. Three-dimensional echocardiography
Three-dimensional TTE and TEE have been part of clinical practice now in excess of 10 years.
Over time, equipment has dramatically improved with the latest TEE matrix array transducers
composed of up to almost 3000 piezoelectric elements. This leap of technology has been
accompanied by improved digital processing power and miniaturization, along with other
software and hardware improvements.
Three-dimensional echocardiography provides a choice of acquisition modes including
multiplane (X-plane), real-time ‘live’ 3D, full-volume (stitched or single beat) 3D, zoom 3D and
3D color Doppler. Live 3D and 3D zoom modes are single-beat acquisitions and represent
cardiac structure and function in real time. Full-volume acquisitions have the option of
‘stitching’ sequential volume datasets over a few cardiac cycles, providing a larger field of
view. Single-beat full volume is available; however, it is limited by reduced temporal and
spatial resolution.
5.4.1. Vegetation
The role of 3D echocardiographic imaging of vegetations is not well studied. A few case reports
or small series confirm, as would be expected, that 3D TEE provides better morphological
characterization and localization of lesions compared to 2D TEE. Three-dimensional TEE was
shown to improve detection of vegetations in some case reports [88–91]; however, small
vegetations may theoretically be more reliably detected with 2D due to higher temporal and
spatial resolution.
A major benefit of 3D is the ability to visualize the entire valve and annulus in a single beat,
enabling identification of eccentrically located vegetations that may otherwise be missed on a
standard 2D TEE examination. Also, 3D imaging provides more accurate assessment of
vegetation size. In a direct comparison by Berdejo et al. [92], mitral vegetation length of ≥16
mm on 2D and ≥20 mm with 3D best predicted embolic events.
5.4.2. Abscess
There are no published data to reliably estimate the diagnostic accuracy of 3D TTE or TEE for
detection of abscess. However, 3D TEE imaging has been shown in case reports to provide
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useful additional information regarding the periannular extent of abscess and the relation to
surrounding anatomical structures, including the coronary arteries [90, 93].
5.4.3. Other complications
Three-dimensional imaging enables valve perforations to be viewed ‘en face’ providing precise
localization and sizing of any defect, while a small number of case reports indicate a higher
detection rate when compared to 2D TEE [94, 95]. One drawback of 3D is artifactual ‘dropout’,
especially with thin valvular tissue and suboptimal gain settings, which can result in false-
positive findings. To confirm the finding, the defect should be visualized in systole and diastole
and associated with a thickened rim surrounding the perforation [96]. Finally, 3D may assist
with surgical planning when repair is contemplated [94, 96].
Three-dimensional TEE has the potential to demonstrate the extent and location of a valve
aneurysm with greater accuracy than 2D imaging [97]. Similarly with perivalvular dehiscence,
3D is able to define the anatomic spatial relationship to surrounding structures and accurately
define the location, size, and extent of the pathology [93]. One study showed the added benefit
of 3D contrast TTE for accurately delineating the size and extent of a left ventricular pseudoa-
neurysm, when compared to 2D contrast TTE [98].
The role of 3D echo for right-sided IE is restricted to case reports and small case series [99,
100]. Sungur et al. [101] published the first study that compared 3D versus 2D TEE in tricuspid
valve endocarditis against the gold standard of surgery. Three-dimensional imaging provided
en-face visualization of all three TV leaflets in nine of 10 cases, allowing accurate identification
and localization of multiple vegetations. In addition, 3D was able to better characterize
vegetation morphology and size. Three-dimensional TEE also identified a tricuspid annular
abscess that was missed on 2D TEE imaging. Three-dimensional TEE may add incremental
value in localizing vegetations that are partly obscured by reverberation artifact on 2D
imaging [99]. Because the right heart is located anteriorly in the chest, 3D TTE is particularly
useful and has the potential to provide better imaging of the tricuspid valve.
5.5. Limitations of echocardiography
Echocardiography, especially TTE, has a number of potential limitations due to patient and
nonpatient factors. TTE image quality is influenced by body habitus, chest wall deformity, rib
space size, and interposing lung tissue. Poor TTE image quality is the main factor accounting
for the superior diagnostic accuracy of TEE [54].
Furthermore, the skills of the sonographer and echocardiologist also influence diagnostic
accuracy as shown by interobserver variability. Clinical history is important to the reporting
echocardiographer but may result in bias with a trade-off between sensitivity and specificity
[102, 103].
The ultrasound equipment, machine settings, and transducer frequency all impact on diag-
nostic accuracy. The limits of image resolution allow detection of vegetations down to 1.5–2
and 3–4 mm, for TEE and TTE, respectively. Not surprisingly, it has been shown that smaller
vegetation size reduces the sensitivity of TTE [54, 104].
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Mimickers of vegetations are often responsible for false-positive findings. Examples include
degenerative valvular tissue, calcification, flail chords, thrombus, tumor, artifact from calcium
or prosthetic material, and even normal anatomical variants such as a prominent Eustachian
valve. Small thin linear strands are common and are frequently seen on native valves along
the leaflet coaptation zone and may be confused with vegetations. Also, small sterile strands
are frequently (18–43%) seen on prosthetic valves and are of uncertain significance [105].
The limitations outlined underscore the need to repeat imaging in due course (usually within
one week) if the initial TTE and TEE are both negative, but there remains ongoing clinical
suspicion of IE.
6. Echocardiographic predictors of prognosis
Embolism occurs in approximately one-quarter to one-half of patients [106, 107] with endo-
carditis, but the risk is substantially reduced after initiation of antibiotics within the first 1–2
weeks [111, 114]. Large mobile vegetations are associated with more complications. Vegeta-
tions >10 mm in length [55, 106, 110] and mobile masses carry the greatest risks of embolism
[106, 111, 112].
Vegetations >15 mm and high mobility pose a major risk of systemic embolism [113]. Previous
embolism, change in size of vegetations, S. aureus, and mitral valve location increase the risk
of new embolism [114]. Right-sided vegetations ≥20 mm portend a poor prognosis, with
mortality similar to that of left-sided IE [39, 40].
Echocardiography is very useful at identifying important prognostic markers related to extent
of infection, cardiac function, and hemodynamics. Predictors of outcome include periannular
extension, severe valvular dysfunction, left and right ventricular systolic function, left atrial
size, left ventricular size, left ventricular filling pressures, and pulmonary artery pressure [1,
110, 115, 116]. More specifically, in left-sided native valve S. aureus endocarditis, an LVEF <40%
or presence of abscess independently predicts in-hospital mortality while abscess and leaflet
perforation both independently predict 12-month mortality [117].
7. Surgery and the role of echocardiography
Although patients may respond to prolonged antibiotic therapy alone, up to 50% will require
surgical intervention [118]. Early surgery within the first week of antimicrobial therapy can
improve survival in complicated left-sided IE; however, it may increase the risk of relapse and
prosthetic valve dysfunction [119]. Echocardiography is fundamental in identifying important
complications and prognostic markers that influence the timing of surgery.
Heart failure and embolism are the leading causes of mortality. Early surgery for left-sided IE
is generally indicated in the following circumstances: (a) congestive cardiac failure, (b)
periannular extension, for example, abscess and fistula, (c) large vegetations (>30 mm or
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possibly >15 mm) or recurrent emboli (>10 mm), (d) difficult to treat organisms such as S.
aureus, multiresistant microbes, or fungi, (e) prosthetic valve endocarditis especially with
Gram-negative, non-HACEK organisms, and (f) persistent sepsis or uncontrolled intracardiac
infection including enlarging vegetations, despite appropriate antibiotics [17, 27].
Perioperative pre-pump 2D and 3D TEE provides the surgeon with a comprehensive real-time
assessment of the extent of intracardiac pathology and cardiac hemodynamic status immedi-
ately prior to the procedure. A decision can be made on the feasibility of repair versus valve
replacement and allows planning of the surgical strategy. The postpump TEE assesses cardiac
function, hemodynamics, and the adequacy of surgical procedure. In addition, imaging can
ensure the heart is appropriately ‘de-aired’ prior to removal of the cardiac vent. Intraoperative
TEE for IE has been shown to positively impact on at least one of these factors in approximately
one-third of operations [120].
8. Image optimization
8.1. Two-dimensional echocardiography
Image optimization is particularly important in IE to ensure early diagnosis and accurate
identification of complications. Despite advances in TTE imaging quality, TEE still provides
superior diagnostic capability. A TEE probe is in close proximity to the heart, with minimal
intervening tissues and therefore less attenuation of the ultrasound waves. This allows the use
of a higher frequency (5–7.5 MHz) transducer and provides superior spatial resolution.
The same principles of image optimization apply to both TTE and TEE. To obtain superior
spatial resolution, select the highest frequency transducer that will maintain adequate depth
penetration. Position the focal zone adjacent to the region of interest and adjust depth and
sector width to optimize spatial and temporal resolution [47, 121]. Gain, time gain compensa-
tion (TGC), and dynamic compression of the gray scale are adjusted to optimize image contrast,
while zoom function in real time improves spatial and temporal resolution [122].
8.2. Three-dimensional echocardiography
Three-dimensional image resolution is dependent on the quality of the 2D picture; therefore,
optimizing the image prior to changing to 3D mode is essential. Select the imaging plane or
acoustic window with the highest resolution. Imaging in the axial plane provides superior
resolution (0.5–1 mm) followed by lateral (1.5–2 mm) and finally elevational resolution (2.5–3
mm) [123]. When performing 3D TTE, select the window that transects the structure of interest
through the axial and lateral plane such as the parasternal long axis for the mitral valve.
To allow for optimal postprocessing, it is recommended the gain, compensation, and com-
pression be in the midrange, with the TGC adjusted to display a uniform, slightly brighter
image [124]. As spatial resolution increases, temporal resolution is reduced and vice versa.
This is due to the limited number of scan lines that can be performed in a fixed period of time.
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To improve image resolution, narrow the sector width and optimize frequency, compression,
and focus [124, 125].
Multibeat 3D volume rendered image acquisition is limited by ‘stitching’ artifact from
respiration and/or arrhythmia [124]. This can be addressed with breath holding and ensuring
image acquisition during regular R-R intervals on the ECG.
Cropping of the 3D dataset can be performed en cart prior to image storage or alternatively,
offline on a workstation using proprietary software. The 3D data can then be displayed as
volume rendered format and surface rendered format or 2D tomographic slices [123].
Finally, the 3D rendered image is rotated and orientated according to convention. The mitral
valve from the left atrial perspective (surgeon’s view) with the aorta superiorly (12 o’clock),
the aortic valve with the right coronary cusp inferiorly (6 o’clock), the tricuspid valve with the
interventricular septum inferiorly (6 o’clock), and the pulmonary valve with the anterior cusp
superiorly (12 o’clock). The display formats remain the same regardless of whether the valve
is viewed from above or below [124].
9. Imaging protocol for infective endocarditis
Imaging for IE requires a methodical approach and follows the same principles for TTE and
TEE. All standard TTE and/or TEE transducer positions and views should be obtained with
meticulous scrutiny of the cardiac valves and periannular tissues. Use zoom mode to focus on
each valve individually to ensure subtle pathology is not overlooked.
It is important to pan through the cardiac valves and adjacent supporting structures using
multiple angles and off-axis imaging. This can be achieved with TEE probe manipulation, such
as anteflexion, retroflexion, lateral flexion, probe turning, and probe advancement or with-
drawal. Careful manipulation of the probe is required to avoid trauma or perforation of the
upper gastrointestinal tract. Similarly, the TTE transducer can be angulated, rotated, or
repositioned on the chest wall to maximize diagnostic utility.
With the introduction of multiplane TEE, the 2D image can be effortlessly rotated through 180
degrees. Thorough inspection of the valves, with 2D and color flow Doppler, should be
undertaken at frequent intervals, as the angle is increased. This is particularly useful for
detecting mitral annular complications and/or localized perivalvular regurgitation.
Interrogation of valvular function with color Doppler along with hemodynamic assessment is
essential. Attention should be paid to abnormal color flow arising from valves, fistulae, or other
shunts. Images along the direction and path of any pathological color flow are used to identify
abnormal communications and exclude jet lesions. Assess cardiac chambers for mural
vegetations and the vasculature for endarteritis.
Finally, it is imperative to complete a comprehensive echocardiographic study to assess cardiac
function, hemodynamics, filling pressures, and pulmonary artery pressure.
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Three-dimensional functionalities such as X-plane, real-time, and multibeat 3D should be
routinely incorporated, especially for TEE examination of the mitral and aortic valves.
Transthoracic 3D of the tricuspid valve is useful for assessing valve anatomy and pathology,
particularly in patients with regurgitation associated with pacing leads [126]. For valvular
complications of endocarditis, 3D zoom is preferred, providing good spatial and temporal
resolution with a single-beat acquisition [123]. However, if assessing extensive perivalvular
pathology or ventricular size and function, then change to a wide-angle full-volume 3D
multibeat acquisition.
10. Quality control
Leading echocardiography laboratories must ensure that high standards are accomplished
both for clinical practice and for scientific research. Recommendations for core laboratories,
including quality control guidelines, have been published by the American Society of Echo-
cardiography [108, 127] and European Association of Echocardiography (Cardiovascular
Imaging) [128]. Periodic auditing of stored images and reports should be undertaken and
reviewed by an experienced physician. Echocardiographic findings of endocarditis should
undergo pathological correlation with surgery or a complimentary imaging modality, such as
cardiac CT.
For a center to develop excellence in endocarditis management, a dedicated imaging and
clinical database should be established for auditing, quality control, and research purposes.
Recent guidelines recommend the establishment of a specialized multidisciplinary team at
centers with expertise in managing IE [109]. This approach has been demonstrated to reduce
mortality by over 50% [129]. The endocarditis team should be engaged early in the manage-
ment of suspected IE and urgent echocardiography performed.
The lead echocardiologist should have expertise in the field of cardiac infection and provide
ongoing education to medical colleagues and sonographers alike to ensure the highest imaging
standards are met. When IE is suspected on echo, expert interpretation of the findings should
be communicated urgently to the treating team, especially when significant pathology is
identified. The echocardiologist is also able to advise of any requirement for a supplemental
procedure, such as TEE or CT, and provide recommendations with regard to appropriate
follow-up imaging [17, 27, 109, 130].
11. Complimentary imaging modalities and future directions
11.1. Intracardiac echocardiography
Intracardiac echocardiography (ICE) has the potential to provide better image quality than
TEE due to its use of higher frequency ultrasound in close proximity to the right-sided cardiac
structures. Narducci et al. [79] directly compared the two modalities, with ICE detecting more
intracardiac masses than TEE (Table 4).
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Consider using ICE, particularly in CDRIE where TEE is inconclusive or discordant with
clinical findings. Although ICE is considered a safe procedure [131, 132], its routine use is
limited by cost. Future applications include the use of 3D ICE and electroanatomic mapping
[131].
11.2. Contrast echocardiography
The application of targeted microbubbles and molecular contrast imaging offers promise as
an emerging field of research. Contrast agents could be designed to tag certain cellular or
molecular markers, such as inflammatory cells or ligands, enabling contrast imaging to detect
the presence, location, and extent of the targeted pathology [133].
11.3. Cardiac computed tomography
Multislice CT shows similar diagnostic performance to TEE for detection of large native and
prosthetic valve vegetations, valve aneurysm, abscess, and pseudoaneurysm and provides
superior anatomical detail relating to the extent of periannular extension and relation to
surrounding structures. Vegetations ≤4 mm and small valvular leaflet perforations are not well
detected by CT [84, 134–136]. CT is very helpful for imaging the coronary arteries prior to
surgery and for detecting extracardiac complications of endocarditis [134]. A major drawback
is the exposure to ionizing radiation.
11.4. Positron emission tomography and fusion imaging
There is interest also in nuclear molecular techniques, in particular 18F-fluorodeoxyglucose
(FDG) PET/CT or PET/CTA, as a complimentary modality to echocardiography, especially
when TEE is negative in the very early stages of infection and clinical suspicion remains high
[136, 137]. 18F-FDG is taken up avidly by leukocytes and therefore identifies regions of
inflammation. The CT scan provides complimentary anatomical information. The use of PET/
CT has been shown to substantially improve the sensitivity and thus diagnostic utility of the
modified Duke criteria for diagnosis of both prosthetic valve endocarditis and cardiac device-
related infections [138].
11.5. Cardiac magnetic resonance imaging
Contrast cardiac MRI can potentially detect early periannular extension of infection and may
also identify vegetations, although with less accuracy [139]. The role of cardiac MRI in this
domain remains undefined. MRI is useful for diagnosing cerebral complications of IE [17, 136].
11.6. Molecular imaging
Potential techniques include bioluminescence and radiolabeled antibodies or leukocytes, to
target bacteria, biofilms, fibrin, and sites of inflammation. Bioluminescence requires optical
imaging, while radiolabeling uses PET, SPECT, or combined modalities [140]. These experi-
mental techniques may have applications such as detection of infected vascular grafts or
intracardiac infection [136].
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12. Summary
Echocardiography is fundamental in the management of all aspects of endocarditis from
diagnosis, identifying complications and prognostic factors through to guiding surgery, and
providing follow-up after treatment. Over the past 40 years, since the introduction of M-mode,
echocardiography has evolved rapidly, with high-quality 2D and 3D imaging now in routine
clinical use. Echocardiography is readily available, cost-effective, and safe, without exposure
to ionizing radiation.
Confirming the diagnosis of endocarditis has never been easier with modern era echo;
however, mortality remains high, in part due to delayed diagnosis. Maintaining a high-clinical
suspicion for IE in at-risk patients must be combined with early referral for echo to ensure
prompt diagnosis and institution of appropriate therapy. Formation of an expert multidisci-
plinary IE team and appropriate use of echocardiography has the potential to save lives and
improve patient outcomes.
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